Publications by authors named "Youqi Huang"
Real-world pharmacovigilance study of FDA adverse event reporting system events for finerenone.
Expert Opin Drug Saf
October 2024
Article Synopsis
- This study examined adverse events linked to finerenone utilizing data from the FDA's Adverse Event Reporting System (FAERS) to enhance its safe use in medical settings.
- Data from Q3 2021 to Q4 2023 was analyzed, yielding 905 cases where finerenone was the main suspect for adverse events, primarily affecting older adults aged 65-85.
- Frequent adverse events included decreased glomerular filtration rate and hyperkalemia; the findings suggest significant new safety signals that could help in monitoring risks associated with finerenone in clinical practice.
This review used traditional and network meta-analyses (NMA) to conduct a comprehensive study of antithrombotic therapies in children with thromboembolic disease. We searched the PubMed, Embase, Cochrane Library, Web of Science and ClinicalTrials.gov databases from their inception to 26 February, 2023.
View Article and Find Full Text PDFBackground: Seasonal influenza epidemic occurs every year in Guangzhou, which can affect all age groups. Young children are the most susceptible targets. Parents can decide whether to vaccinate their children or not based on their own consideration in China.
View Article and Find Full Text PDF